Barclays Forecasts Strong Price Appreciation for Tandem Diabetes Care (NASDAQ:TNDM) Stock
Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) had its price objective boosted by equities researchers at Barclays from $58.00 to $60.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical device company’s stock. Barclays‘s target price would suggest a potential upside of 92.86% […]
More Stories
AppLovin (NASDAQ:APP) Given New $270.00 Price Target at Macquarie
AppLovin (NASDAQ:APP – Free Report) had its price target upped by Macquarie from $150.00 to $270.00 in a report released...
Wolfspeed (NYSE:WOLF) Given New $11.00 Price Target at Susquehanna
Wolfspeed (NYSE:WOLF – Free Report) had its target price cut by Susquehanna from $16.00 to $11.00 in a research report...
Take-Two Interactive Software (NASDAQ:TTWO) Given New $181.00 Price Target at Robert W. Baird
Take-Two Interactive Software (NASDAQ:TTWO – Free Report) had its price target boosted by Robert W. Baird from $172.00 to $181.00...
Warner Bros. Discovery (NASDAQ:WBD) Announces Earnings Results
Warner Bros. Discovery (NASDAQ:WBD – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.05 earnings...
Tripadvisor (NASDAQ:TRIP) Given New $17.00 Price Target at UBS Group
Tripadvisor (NASDAQ:TRIP – Free Report) had its target price lowered by UBS Group from $18.00 to $17.00 in a report...
JMP Securities Issues Positive Forecast for Vertex (NASDAQ:VERX) Stock Price
Vertex (NASDAQ:VERX – Free Report) had its price objective boosted by JMP Securities from $47.00 to $61.00 in a research...